The body appears to adapt to both the delayed gastric emptying effects and the central nervous system appetite-suppressing signals, resulting in reduced nausea, vomiting, and other GI symptoms even as doses increase to therapeutic levels
Accessed at pubmed.ncbi.nlm.nih.gov/21844879
Ongoing Support & Follow-Up: After the injection, support doesnt end
Monday to Friday | 11 am to 8 pm Saturday & Sun | 11 am to 6 pm Closed on public holidays Semaglutide is a GLP-1 (Glucagon like Peptide-1) analogue, which mimics the naturally occurring hormone GLP-1 to binds to the GLP-1 receptor in the gut, pancreas and brain
They also boost insulin production in the pancreas and suppress glucagon production, both of which help normalize blood sugars
How Insulin Resistance Develops Multiple factors contribute to insulin resistance: Excess weight: Particularly visceral fat (around organs in the midsection), which is metabolically active and releases substances that impair insulin signaling